Evidence map›Paper›PMID 42056681›Full record

ArticleTargeted oncology2026

Correction: Real-World Outcomes of Sequential Afatinib and Osimertinib Versus Afatinib and Chemotherapy in EGFR-Mutant NSCLC: Taiwan Multicenter GIANT Study.

How-Wen Ko, Ying-Ting Liao, Sheng-Kai Liang, Yen-Hsiang Huang, Yu-Ching Lin, Ping-Chi Liu, Chin-Chou Wang, Jeng-Shiuan Tsai, Yuh-Min Chen, Jin-Yuan Shih and 2 more

Abstract readPublished Erratum
In one paragraph

Article in Targeted oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

How-Wen KoDivision of Pulmonary Oncology and Interventional Bronchoscopy, Department of Chest Medicine, Linkou Chang Gung Memorial Hospital, No.5, Fuxing Street, Guishan District, Taoyuan City, 333, Taiwan.
Ying-Ting LiaoDepartment of Chest Medicine, Taipei Veterans General Hospital, Taipei, 112, Taiwan.
Sheng-Kai LiangDepartment of Medicine, National Taiwan University Cancer Center, Taipei, 100, Taiwan.
Yen-Hsiang HuangDepartment of Chest Medicine, Taichung Veterans General Hospital, Taichung, 407, Taiwan.
Yu-Ching LinCollege of Medicine, Chang Gung University, Taoyuan City, 333, Taiwan.
Ping-Chi LiuDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Respiratory Therapy, Keelung Chang Gung Memorial Hospital, Keelung, 204, Taiwan.
Chin-Chou WangDivision of Pulmonary & Critical Care Medicine, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, 833, Taiwan.
Jeng-Shiuan TsaiDivision of Chest Medicine, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, 704, Taiwan.
Yuh-Min ChenHead of Clinical Research Center, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
Jin-Yuan ShihDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei, 100, Taiwan.
Tsung-Ying YangDepartment of Chest Medicine, Taichung Veterans General Hospital, Taichung, 407, Taiwan.
Cheng-Ta YangDivision of Pulmonary Oncology and Interventional Bronchoscopy, Department of Chest Medicine, Linkou Chang Gung Memorial Hospital, No.5, Fuxing Street, Guishan District, Taoyuan City, 333, Taiwan. yang1946@cgmh.org.tw.ORCID http://orcid.org/0000-0003-1846-1027

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42056681
PMCPMC13427992

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.